Comerica Bank’s Syndax Pharmaceuticals SNDX Stock Holding History

Comerica Bank’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$15.1K	Hold	719	–	–	﹤0.01%	3151
2025 Q3	$11.1K	Buy	719 +707	+5,892%	+$9.25K	﹤0.01%	3225
2025 Q2	$112	Sell	12 -1,050	-99%	-$11.6K	﹤0.01%	3667
2025 Q1	$13K	Buy	1,062 +99	+10%	+$1.4K	﹤0.01%	3119
2024 Q4	$12.7K	Buy	963 +5	+0.5%	+$86	﹤0.01%	3139
2024 Q3	$18.4K	Buy	958 +7	+0.7%	+$145	﹤0.01%	3053
2024 Q2	$19.5K	Hold	951	–	–	﹤0.01%	3003
2024 Q1	$22.6K	Sell	951 -35	-4%	-$781	﹤0.01%	3001
2023 Q4	$21.3K	Buy	986 +836	+557%	+$12.9K	﹤0.01%	2953
2023 Q3	$2.18K	Buy	+150	New	+$2.84K	﹤0.01%	3556

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Comerica Bank's SNDX Position: Q4 2025 in Review

Comerica Bank held its Syndax Pharmaceuticals (SNDX) position steady in Q4 2025 at 719 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3151.

Comerica Bank first reported a position in SNDX in Q3 2023 and has held it in 10 quarters since. The position peaked at $22.6K in Q1 2024. 229 funds tracked by Wall St. Rank hold SNDX as of Q4 2025.

Comerica Bank held 719 shares of Syndax Pharmaceuticals worth $15.1K as of Q4 2025.
Comerica Bank left its Syndax Pharmaceuticals share count unchanged in Q4 2025.
Syndax Pharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3151 holding.
Comerica Bank first reported a position in Syndax Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Syndax Pharmaceuticals position peaked at $22.6K in Q1 2024.
229 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.